© 2021 MJH Life Sciences™ and Urology Times. All rights reserved.
Novartis offers zoledronic acid injection (ZOMETA) for the treatmentof patients with documented bone metastases from solid tumors, includingprostate cancer, in conjunction with standard antineoplastic therapy.
Related Content: